Akt as a potential prognostic marker in neuroendocrine tumours: a possibility?

Angela Hague, Helen Louise Robbins

Research output: Contribution to journal › Editorial (Academic Journal)

239 Downloads (Pure)

Abstract

[no abstract]
Original languageEnglish
Pages (from-to)281-284
Number of pages4
JournalInternational Journal of Endocrine Oncology
Volume3
Issue number4
DOIs
Publication statusPublished - 1 Nov 2016

Keywords

  • Neuroendocrine tumours
  • Akt
  • p-Akt
  • mTOR
  • everolimus
  • biomarker

Access to Document

  • Full-text PDF (accepted author manuscript)

    This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Future Publishing at http://www.futuremedicine.com/doi/abs/10.2217/ije-2016-0019. Please refer to any applicable terms of use of the publisher.

    Accepted author manuscript, 424 KB

Handle.net

    Fingerprint

    Dive into the research topics of 'Akt as a potential prognostic marker in neuroendocrine tumours: a possibility?'. Together they form a unique fingerprint.
    View full fingerprint

    Cite this